Stonewise
The AI engine Fit Assessment
BetaStoneWise effectively leverages machine learning and integrates various scientific disciplines to enhance drug discovery, thereby expanding therapeutic options.
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
- Drug Discovery Optimization
Developer of an artificial Intelligence platform designed to accelerate novel drug discovery. The company's platform is designed by cutting-edge technologies such as artificial intelligence and microfluidics, integrated with computational chemistry, computational biology, pharmacology and clinical medicine. The company's platform provides a vast range of services such as medical knowledge graphs, molecular generation and design, ADMET prediction etc., improving the efficiency and success rate of early stage drug discoveries.